Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03341156 · ClinicalTrials.gov registry record · Phase 3
Administration of Prothrombin Complex Concentrate vs. Standard Transfusion During/After Heart Transplantation
A Phase 3 study, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- Phase 3
- Development phase
- 14
- Enrollment target
NCT03341156: Clinical Trial Phase 3 study, sponsored by University of Maryland, Baltimore.
NCT03341156 is a Phase 3 study that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 14 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03341156, a Phase 3 study, was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study is comparing the use of Kcentra vs. standard transfusion in patients undergoing heart transplantation surgery. Half of the patients will receive Kcentra, while the other half will receive fresh frozen plasma.
Primary Outcome
Primary outcome: Amount of chest tube output in the first 24 hours
Interventions
- DRUG Kcentra
- DRUG Frozen Plasma Product, Human
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-07-11 |
| Est. Completion | 2025-02-20 |
| Phase | Phase 3 |
Why NCT03341156 stopped before completion
NCT03341156 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Kcentra is the first listed.
NCT03341156 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03341156 about?
NCT03341156 is a clinical study titled "Administration of Prothrombin Complex Concentrate vs. Standard Transfusion During/After Heart Transplantation". This study is comparing the use of Kcentra vs. standard transfusion in patients undergoing heart transplantation surgery. Half of the patients will receive Kcentra, while the other half will receive fresh frozen plasma.
What is the current status of trial NCT03341156?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 14 participants. The study started on 2018-07-11. Estimated completion is 2025-02-20.
What interventions are being tested in trial NCT03341156?
The interventions under investigation include: Kcentra (DRUG), Frozen Plasma Product, Human (DRUG).
Who is sponsoring clinical trial NCT03341156?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03341156's enrollment target sits among peer trials
14 1983rd of 2000 higher than 17 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy